Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03797521 · ClinicalTrials.gov registry record · Phase 2

A Study in Patients With Trichotillomania

A Phase 2 study of Trichotillomania, sponsored by Promentis Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
128
Enrollment target
13
Study locations

NCT03797521 is a Phase 2 study of Trichotillomania that has completed, run by Promentis Pharmaceuticals. The registered enrollment target is 128 participants, above the 56-participant average among 8 other Trichotillomania trials with a reported enrollment target (129% higher). The trial reports 13 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03797521, a Phase 2 study of Trichotillomania, has completed, sponsored by Promentis Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
128 participants
Enrollment target
13
Study locations

Study Summary

The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 when dosed for 6 weeks versus placebo in adult patients with moderate to severe Trichotillomania.

Conditions Studied

Trichotillomania

Interventions

  • DRUG Placebo
  • DRUG SXC-2023

Study Locations (13)

California

  • CNRI- Los Angeles - Pico Rivera
  • Artemis Institute for Clinical Research - Riverside

New York

  • Integrative Clinical Trials, LLC - Brooklyn
  • Finger Lakes Clinical Research - Rochester

Florida

  • Behavioral Clinical Research - North Miami

Georgia

  • iResearch Atlanta - Decatur

Illinois

  • Univ of Chicago - Chicago

Louisiana

  • Lake Charles Clinical Trials - Lake Charles

Massachusetts

  • Massachusetts General Hospital - Boston

Ohio

  • Insight Clinical Trials, LLC - Shaker Heights

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2018-12-19
Est. Completion 2019-12-16
Phase Phase 2

Sponsor

Promentis Pharmaceuticals

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03797521

The ClinicalTrials.gov registry entry for NCT03797521 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 56-participant average among 8 other Trichotillomania trials with a reported enrollment target (129% higher). The listed sponsor is Promentis Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trichotillomania appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03797521 reports 13 study locations spanning 11 distinct geographic areas - top geographies include California, New York, Florida.

Frequently Asked Questions

What is clinical trial NCT03797521 about?

NCT03797521 is a clinical study titled "A Study in Patients With Trichotillomania". The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 when dosed for 6 weeks versus placebo in adult patients with moderate to severe Trichotillomania.

What is the current status of trial NCT03797521?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2018-12-19. Estimated completion is 2019-12-16.

What conditions does trial NCT03797521 study?

This clinical trial studies the following conditions: Trichotillomania.

What interventions are being tested in trial NCT03797521?

The interventions under investigation include: Placebo (DRUG), SXC-2023 (DRUG).

Who is sponsoring clinical trial NCT03797521?

This trial is sponsored by Promentis Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03797521 being conducted?

This trial has 13 study locations across California, Florida, Georgia, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trichotillomania

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Trichotillomania

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.